SC
AGN

Sculptor Capital’s Allergan plc AGN Stock Holding History

Sculptor Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27,100
Closed -$7.26M – 438
2016
Q1 		$7.26M Buy
+27,100
New +$7.76M 0.04% 218
2015
Q1 		– Sell
-26,500
Closed -$6.82M – 805
2014
Q4 		$6.82M Hold
26,500
– – 0.02% 413
2014
Q3 		$6.39M Buy
26,500
+25,000
+1,667% +$5.59M 0.02% 466
2014
Q2 		$335K Hold
1,500
– – ﹤0.01% 720
2014
Q1 		$309K Sell
1,500
-600
-29% -$119K ﹤0.01% 707
2013
Q4 		$353K Buy
+2,100
New +$328K ﹤0.01% 723

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Sculptor Capital's AGN Position: Q2 2020 in Review

Sculptor Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 234,328 shares — an estimated $41.5M sold.

Sculptor Capital first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $1.17B in Q3 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Sculptor Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Sculptor Capital sold 234,328 Allergan plc shares in Q2 2020, an estimated $41.5M.
  • Sculptor Capital first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • Sculptor Capital's Allergan plc position peaked at $1.17B in Q3 2014.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Sculptor Capital's 13F filing for Q2 2020, filed 14 Aug 2020.